Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation

ABACUS/Manakin Repository

Show simple item record

dc.contributor.author Martínez Sellés Oliveria Soares, Manuel
dc.contributor.author Bouza, Emilio
dc.contributor.author Díez-Villanueva, Pablo
dc.contributor.author Valerio, Maricela
dc.contributor.author Fariñas, María Carmen
dc.contributor.author Muñoz García, Antonio Jesús
dc.contributor.author Gálvez-Acebal, Juan
dc.contributor.author Antorrena, Isabel
dc.contributor.author Hera Galarza, Jesús María de la
dc.contributor.author Navas, Enrique L.
dc.contributor.author Muñoz, Patricia
dc.date.accessioned 2017-01-04T12:37:28Z
dc.date.available 2017-01-04T12:37:28Z
dc.date.issued 2016
dc.identifier.citation Martínez-Sellés, M., Bouza, E., Díez-Villanueva, P., Valerio, M., Fariñas, M. C., Muñoz-García, A. J., ... & Navas, E. (2016). Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation. EuroIntervention, 10(11), 1180-1186. DOI: 10.4244/EIJY15M02-05 spa
dc.identifier.issn 1774024X
dc.identifier.uri http://hdl.handle.net/11268/6134
dc.description.abstract The aim of this study is to describe the characteristics of infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI). This study was performed using the GAMES database, a national prospective registry of consecutive patients with IE in 26 Spanish hospitals. Of the 739 cases of IE diagnosed during the study, 1.3% were post-TAVI IE, and these 10 cases, contributed by five centres, represented 1.1% of the 952 TAVIs performed. Mean age was 80 years. All valves were implanted transfemorally. IE appeared a median of 139 days after implantation. The mean age-adjusted Charlson comorbidity index was 5.45. Chronic kidney disease was frequent (five patients), as were atrial fibrillation (five patients), chronic obstructive pulmonary disease (four patients), and ischaemic heart disease (four patients). Six patients presented aortic valve involvement, and four only mitral valve involvement; the latter group had a higher percentage of prosthetic mitral valves (0% vs. 50%). Vegetations were found in seven cases, and four presented embolism. One patient underwent surgery. Five patients died during follow-up: two of these patients died during the admission in which the valve was implanted. Conclusions: IE is a rare but severe complication after TAVI which affects about 1% of patients and entails a relatively high mortality rate. IE occurred during the first year in nine of the 10 patients. spa
dc.description.sponsorship SIN FINANCIACIÓN spa
dc.language.iso eng spa
dc.title Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation spa
dc.type article spa
dc.description.impact 5.193 JCR (2016) Q1, 24/126 Cardiac and Cardiovascular Systems spa
dc.identifier.doi 10.4244/EIJY15M02-05
dc.rights.accessRights closedAccess spa
dc.subject.uem Endocarditis infecciosa spa
dc.subject.uem Válvulas cardíacas spa
dc.subject.unesco Enfermedad cardiovascular spa
dc.subject.unesco Sistema cardiovascular spa
dc.description.filiation UEM spa
dc.peerreviewed Si spa

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record